Reports

• Opioids in Medicare Part D: Concerns about Extreme Use and Questionable Prescribing

  

• Advisory Opinion 17-02

  

• Part D Plans Generally Include Drugs Commonly Used by Dual Eligibles: 2017

  

• Wisconsin Physicians Service Insurance Corporation Did Not Properly Settle Missouri Medicare Disproportionate Share Hospital Payments

  

• Public Summary Report: Readiness of CDCs Strategic National Stockpile Could Be at Risk in Case of a Public Health Emergency

  

• Ariel Foundation Against Pediatric AIDS Managed and Expended the Presidents Emergency Plan for AIDS Relief Funds in Accordance with Award Requirements

  

• T-MSIS Data Not Yet Available for Overseeing Medicaid

  

• Management and Development for Health Did Not Always Manage the Presidents Emergency Plan for AIDS Relief Funds in Accordance With Award Requirements

  

• 2016 Performance Data for the Senior Medicare Patrol Projects

  

• Medicare Paid Hundreds of Millions in Electronic Health Record Incentive Payments That Did Not Comply With Federal Requirements

  

• Review of Wisconsin Medicaid Managed Care Program Potential Savings With Minimum Medical Loss Ratio

  

• Medicare Market Shares of Mail Order Diabetes Test Strips From October Through December 2016

  

• Round 2 Competitive Bidding for CPAP/RAD: Disrupted Access Unlikely for Devices, Inconclusive for Supplies

  

• Spring 2017 Semiannual Report to Congress

  

• Minnesota Disbursed Only Part of Its Civil Money Penalty Collections, Limiting Resources To Protect and Improve Care for Nursing Facility Residents

  

• CDC Generally Met Its Inspection Goals for the Federal Select Agent Program; However, Opportunities Exist To Strengthen Oversight

  

• FY 2018 Congressional Budget Justification

  

• Medicare Could Save Millions by Eliminating the Lump-Sum Purchase Option for All Power Mobility Devices

  

• Public Summary Report: Virginia Did Not Adequately Secure Its Medicaid Data

  

• HHS Did Not Identify and Report Antideficiency Act Violations